Integrative Physiology |
From the Cardiology Division, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Correspondence to Tsutomu Yoshikawa, MD, Cardiology Division, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan 160-8582. E-mail tyoshi{at}mc.med.keio.ac.jp
AbstractAlthough immunoapheresis removing autoantibodies against the second extracellular domain of ß1-adrenergic receptors (ARs) improves cardiac function in patients with cardiomyopathy, the underlying mechanisms have not been defined. We examined the role of autoimmunity against the domain in the development of cardiac dysfunction in vivo. Japanese white rabbits were immunized with a synthetic peptide corresponding to the second extracellular loop of ß1-AR once a month with (ß+biso rabbits, n=10) or without (ß rabbits, n=13) bisoprolol treatment (2 mg/kg per day). Control rabbits received vehicle without bisoprolol treatment (n=13). Autoantibodies of IgG isotype against the domain were persistently detected in ß and ß+biso rabbits. Purified IgG from sera of ß and ß+biso rabbits increased cAMP production in a rabbit cardiac membrane preparation, which was blocked by bisoprolol. At 3 months, ß-AR uncoupling with increased G proteincoupled receptor kinase 5 (GRK5) expression was found in ß rabbits. At 6 months, left ventricular hypertrophy was noted with hemodynamic derangements in ß rabbits. This was accompanied by decreased ß1-AR density and increased inhibitory G protein and GRK5 expression, which were related to marked decrease in membrane cAMP production. These changes in ß rabbits at 6 months were prevented in ß+biso rabbits. There was no difference in the plasma norepinephrine concentration in the 3 groups over the observation period. Thus, autoimmunity against the second extracellular loop of ß1-ARs induced profound ß-AR desensitization and myocardial hypertrophy in vivo, associated with cardiac dysfunction. Sustained sympathomimetic-like actions of autoantibodies against the domain may be partly responsible for these changes.
Key Words: autoimmunity cardiomyopathy ß-adrenergic receptor hypertrophy cardiac dysfunction
This article has been cited by other articles:
![]() |
W. Mao, S. Fukuoka, C. Iwai, J. Liu, V. K. Sharma, S.-S. Sheu, M. Fu, and C.-s. Liang Cardiomyocyte apoptosis in autoimmune cardiomyopathy: mediated via endoplasmic reticulum stress and exaggerated by norepinephrine Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1636 - H1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fukuda, S. Miyoshi, K. Tanimoto, K. Oota, K. Fujikura, M. Iwata, A. Baba, Y. Hagiwara, T. Yoshikawa, H. Mitamura, et al. Autoimmunity against the second extracellular loop of beta1-adrenergic receptors induces early afterdepolarization and decreases in K-channel density in rabbits J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1090 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wallukat, J. Muller, and R. Hetzer Specific Removal of {beta}1-Adrenergic Autoantibodies from Patients with Idiopathic Dilated Cardiomyopathy N. Engl. J. Med., November 28, 2002; 347(22): 1806 - 1806. [Full Text] [PDF] |
||||
![]() |
H.-R. Liu, R.-R. Zhao, X.-Y. Jiao, Y.-Y. Wang, and M. Fu Relationship of myocardial remodeling to the genesis of serum autoantibodies to cardiac beta1-adrenoceptors and muscarinic type 2 acetylcholine receptors in rats J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1866 - 1873. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |